Chung Hyung-min
Hyung Min CHUNG | |
|---|---|
 Hyung Min CHUNG | |
| Born | 1964 (age 59–60) |
| Nationality | Korean |
| Alma mater | Kon-Kuk University |
| Known for | Animal Biotechnology & Stem cell research |
| Awards | 2004. The 2004 Society for Assisted Reproductive Technology (SART) Prize Paper "Genes differentially expressed in primordial, primary and secondary follicles by cDNA microarray", 60th Annual meeting for ASRM meeting at Philadelphia, USA. 2009. "CEO of Next generation"(for Bio Technology), Ministry of Knowledge Economy |
| Scientific career | |
| Fields | Stem cell research |
| Institutions | CHA Stem Cell Institute, CHA University |
| Doctoral advisor | Kil Saeng CHUNG |
Education
- 1987 B.Sci. Kon-Kuk University, Department of Animal Biotechnology (major: Animal Biotechnology)
- 1993 Ph.D. Kon-Kuk University, Department of Animal Biotechnology (major: Animal Biotechnology)
- 1998 Visiting Scientist Columbia University, Department of Obstetrics & Gynacology.
Work
Dr. Hyung-Min Chung was appointed professor at CHA University in 1997 after obtaining his BA, MA and Ph.D degree at Konkuk University.
Currently, he is a Professor of biomedical science at CHA Univeristy, Director of CHA Stemcell Institute, President of CHA Bio & Diostech Inc., Member of LMO Assessment Advisory Committee for Ministry of Health and Welfare, and Advisor for the Ministry of Knowledge Economy under the National Technical Advisory Committee. Dr Chung is a prominent leader in the field of stem cell research with over 20 years of experience.
His research aims at the development of stem cell therapies using human adult and embryonic stem cells. Primarily, his study focusses on the clinical applications of human embryonic stem cell-derived retinal cells, artificial blood and cardiovascular cells.
His research group became only the second in the world to be approved [citation needed] to conduct clinical application of human embryonic stem cells for the treatment of an orphan disease named Stargardt’s macular dystrophy.
Awards
- Oct. 3, 1998 Second Place Prize Paper, International Federation of Fertility Societies(IFFS) 16th World Congress on Fertility and Sterility and 54th Annual Meeting of the American Society for Reproductive Medicine(ASRM)at San Francisco ("In Vitro Blastocyst Formation of Human Oocytes Vitrified at the Immature, Maturing or Mature Stage"), California, USA.
- Oct. 21. 2000 Best Video Award Winner, American Society for Reproductive Medicine(ASRM), ("Birth of a Baby Developed from Vitrified Oocytes"), 56th Annual Meeting at San Diego, California, USA.
- Oct 16. 2004 The 2004 Society for Assisted Reproductive Technology (SART) Prize Paper "Genes differentially expressed in primordial, primary and secondary follicles by cDNA microarray", 60th Annual Meeting of American Society for Reproductive Medicine(ASRM) at Philadelphia, USA.
- 2009 "CEO of Next generation"(for Bio Technology), Ministry of Knowledge Economy
Publications
- Lee MJ, Kim J, Lee KI, Shin JM, Chae JI, Chung HM. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011 Feb;13(2):165-78. PubMed PMID: 21235296.
- Kim MJ, Park JS, Kim S, Moon SH, Yang HN, Park KH, Chung HM. Encapsulation of Bone Morphogenic Protein-2 with Cbfa1-Overexpressing Osteogenic Cells Derived from Human Embryonic Stem Cells in Hydrogel Accelerates Bone Tissue Regeneration. Stem Cells Dev. 2011 Jan 27. [Epub ahead of print] PubMed PMID:21126165.
- Kim EY, Jeon K, Park HY, Han YJ, Yang BC, Park SB, Chung HM, Park SP. Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts. Cell Reprogram. 2010 Dec;12(6):627-39. Epub 2010 Oct 19. PubMed PMID: 20958217; PubMed Central PMCID: PMC2998986.
- Moon SH, Kim JS, Park SJ, Lim JJ, Lee HJ, Lee SM, Chung HM. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res. 2011 Jan;6(1):50-9. PubMed PMID: 20920899.
- Park SW, Jun Koh Y, Jeon J, Cho YH, Jang MJ, Kang Y, Kim MJ, Choi C, Sook Cho Y, Chung HM, Young Koh G, Han YM. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood. 2010 Dec 16;116(25):5762-72. Epub 2010 Sep 30. PubMed PMID: 20884805.